NSEOutcome of Board Meeting9 Jul 2026 · 9 Jul 2026, 07:38 pm

Outcome of Board Meeting

Virinchi Limited · VIRINCHI

✦ AI SummaryM&A

Virinchi Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2026. The board of directors met and approved the proposal to enter into a Business Transfer Agreement with Virinchi Health Care Private Limited for the acquisition of the Primary and Secondary Healthcare Business Division operated under the "Bristlecone Hospitals" brand, subject to the approval of shareholders.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern2/10
Regulatory Risk4/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Virinchi Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2026.

Attachments (1)

📄

VIRINCHI1303_09072026193751_Outcome_of_Board_Meeting.pdf

pdf

Download →
View document text
9th July, 2026 To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai - 400 051 Scrip Code: 532372 Symbol: VIRINCHI Dear Sir/Madam, Subject: Outcome of the Board Meeting – Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the above subject, the board of directors met on today i.e 9th July, 2026 and approved the following transactions subject to the approval of shareholders. 1. Approved the proposal to enter into a Business Transfer Agreement (“BTA”) with Virinchi Health Care Private Limited (“VHCPL”), a subsidiary of Virinchi Limited (“Company”), for the acquisition of the Primary and Secondary Healthcare Business Division operated under the “Bristlecone Hospitals” brand, together with all related assets, liabilities, contracts, employees and other rights and obligations forming part of the said business division, as a going concern on a slump-sale basis, subject to the approval of the shareholders of the Company and receipt of such other regulatory, statutory or other approvals, consents and permissions as may be required, with the transaction being effective from April 1, 2026. 2. Approved the Postal ballot Notice The meeting commenced at 6.30 p.m. and concluded at 7.15 p.m. This is for your information and records. Thanking you, Yours faithfully, For Virinchi Limited K. Ravindranath Tagore Company Secretary M.No.A18894 In the context of the above, enclosed please find the relevant disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with the SEBI Master Circular dated 11th November, 2024. S.No. Particulars Disclosures 1. Name of the target entity, M/s. Virinchi Health Care Private Limited (“VHCPL”), details in brief such as size, a material subsidiary of M/s. Virinchi Limited, turnover etc.; engaged in the business of healthcare services under the brand name/style Bristlecone Hospitals Located at Barkatpura and Hayathnagar, Hyderabad. The healthcare undertaking proposed to be acquired comprises the business operations together with related assets, liabilities, contracts, employees and other business undertakings, as a going concern on a slump sale basis. 2. Whether the acquisition Yes. VHCPL is a material subsidiary of M/s. Virinchi would fall within related party Limited and accordingly the proposed transaction transaction(s) and whether falls within the ambit of related party transaction. the promoter/ promoter The transaction is proposed to be undertaken on an group/ group companies have arm’s length basis and in the ordinary course of any interest in the entity being business, subject to applicable approvals under the acquired? If yes, nature of Companies Act, 2013 and SEBI (Listing Obligations interest and details thereof and Disclosure Requirements) Regulations, 2015. and whether the same is done at “arm’s length”; 3. Industry to which the entity Healthcare / Hospital and Medical Services Industry. being acquired belongs; 4. Objects and impact of This restructuring is intended to establish a acquisition (including but not dedicated AI-first healthcare platform while limited to, disclosure of enabling Virinchi Hospitals to remain focused on reasons for acquisition of tertiary and quaternary care. The proposal reflects target entity, if its business is the Board's assessment that the future of outside the main line of community healthcare will be increasingly driven by business of the listed entity); Artificial Intelligence, digital operating systems, standardized clinical pathways and scalable delivery models. The Board considers this restructuring proactive and aligned with long-term industry evolution. It enables disciplined investment in AI, software engineering, analytics, interoperability, digital patient engagement, operational excellence and standardized clinical governance. The resulting platform is expected to improve patient outcomes, physician productivity, affordability, scalability, quality assurance and international competitiveness. Virinchi Limited will also be able to leverage common technology assets across multiple hospitals, continuously refine AI models using validated clinical workflows, and build exportable intellectual property. The strategy supports responsible innovation while maintaining the highest standards of patient safety, ethics, transparency and regulatory compliance. The long- term aspiration is to establish Bristlecone Hospitals as one of the world's leading AI-enabled community healthcare brands originating from India. 5. Brief details of any The acquisition is subject to approval of governmental or regulatory shareholders of the Company and such other approvals required for the statutory, regulatory and contractual acquisition; approvals/consents, as may be applicable. 6. Indicative time period for The acquisition is proposed to be completed within completion of the acquisition; such period as may be mutually agreed between the parties, subject to fulfilment of conditions precedent and receipt of requisite approvals. 7. Consideration - whether cash The Company (listed entity) shall not be issuing any consideration or share swap or securities or give any consideration in kind to any other form and details of VHCPL. Loans and advances from Virinchi Limited to the same; VHCPL will be adjusted against the consideration to be paid by Virinchi Limited to VHCPL. 8. Cost of acquisition and/or the The Value of the transaction is Rs.100 Crores( price at which the shares are Rupees One Hundred Crores) acquired; 9. Percentage of shareholding / Not Applicable, as the transaction pertains to control acquired and / or acquisition of healthcare business undertaking on a number of shares acquired; slump sale basis and does not involve acquisition of shares. 10. Brief background about the Virinchi Health Care Private Limited based in entity acquired in terms of Telangana, India was incorporated on 16/12/2013. products/line of business Purchase of the Primary and Secondary Healthcare acquired, date of Business under Bristlecone Hospitals Brand from incorporation, history of last 3 “VHCPL” as a going concern, on a ‘slump sale’ basis. years turnover, country in The Turnover during last 3 years are 13,314.85 which the acquired entity has Lakhs, 10,414.98 Lakhs, 8,299.05 Lakhs respectively. presence and any other significant information (in brief);